Stem Cell Aging Leukemia and Lymphoma (SALL)

Eugene Berezikov
- Faculty of Medical Sciences/UMCG, Stem Cell Aging Leukemia and Lymphoma (SALL)
Person: Scientific Staff
Anke van den Berg
- Faculty of Medical Sciences/UMCG, Stem Cell Aging Leukemia and Lymphoma (SALL)
- Faculty of Medical Sciences/UMCG, Translational Immunology Groningen (TRIGR)
Person: Scientific Staff
Edwin Bremer
- Faculty of Medical Sciences/UMCG, Stem Cell Aging Leukemia and Lymphoma (SALL)
Person: Scientific Staff

Acute systemic loss of Mad2 leads to intestinal atrophy in adult mice
Schukken, K. M., Zhu, Y., Bakker, P. L., Koster, M. H., Harkema, L., Youssef, S. A., de Bruin, A. & Foijer, F., 8-Jan-2021, In: Scientific Reports. 11, 1, 8 p., 68.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
File

17 Downloads (Pure)
Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial
Löwenberg, B., Pabst, T., Maertens, J., Gradowska, P., Biemond, B. J., Spertini, O., Vellenga, E., Griskevicius, L., Tick, L. W., Jongen-Lavrencic, M., van Marwijk Kooy, M., Vekemans, M-C., van der Velden, W. J. F. M., Beverloo, B., Michaux, L., Graux, C., Deeren, D., de Weerdt, O., van Esser, J. W. J., Bargetzi, M. & 28 others, Klein, S. K., Gadisseur, A., Westerweel, P. E., Veelken, H., Gregor, M., Silzle, T., van Lammeren-Venema, D., Moors, I., Breems, D. A., Hoogendoorn, M., Legdeur, M-C. J. C., Fischer, T., Kuball, J., Cornelissen, J., Porkka, K., Juliusson, G., Meyer, P., Höglund, M., Gjertsen, B. T., Janssen, J. J. W. M., Huls, G., Passweg, J., Cloos, J., Valk, P. J. M., van Elssen, C. H. M. J., Manz, M. G., Floisand, Y. & Ossenkoppele, G. J., 23-Feb-2021, In: Blood. 5, 4, p. 1110-1121 12 p.
Research output: Contribution to journal › Article › Academic › peer-review
Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition
Cohen-Sharir, Y., McFarland, J. M., Abdusamad, M., Marquis, C., Bernhard, S. V., Kazachkova, M., Tang, H., Ippolito, M. R., Laue, K., Zerbib, J., Malaby, H. L. H., Jones, A., Stautmeister, L-M., Bockaj, I., Wardenaar, R., Lyons, N., Nagaraja, A., Bass, A. J., Spierings, D. C. J., Foijer, F. & 6 others, Beroukhim, R., Santaguida, S., Golub, T. R., Stumpff, J., Storchová, Z. & Ben-David, U., 18-Feb-2021, In: Nature. 590, 7846, 29 p.
Research output: Contribution to journal › Article › Academic › peer-review

2 Citations (Scopus)

Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma [L1236]
Kluiver, J. (Creator), Slezak, I. (Creator) & van den Berg, A. (Creator), NCBI, 16-Jul-2015
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE70937
Dataset

Best paper of the year at annual Dutch Hematology Congress 2019
Schuringa, Jan Jacob (Recipient), 2019
Prize › Academic
Differential drug sensitivity in pediatric brain cancer precursor cells: towards tailored treatments for infant and childhood medulloblastoma.
Bruggeman, Sophia (Recipient), 19-Jul-2018
Prize: Fellowship awarded competitively › Academic
Dutch Cancer Society postdoctoral fellowship
Foijer, Floris (Recipient), 1-Feb-2007
Prize: Fellowship awarded competitively › Academic

51 Professional or public event
49 Academic event
29 Membership
20 Supervision and examination of PhD students of the UG
More

PhD Mette Dahl
Anke Berg, van den (Member of PhD Examining Committee)
12-Feb-2021
Activity: Examination, teaching and supervision › Examination, teaching and supervision external institution › Academic
NextLevel Twinning project kickoff meeting
Anke Berg, van den (Contributor)
19-Jan-2021
Activity: Organising and attending an event › Organising and contributing to an event › Academic
Abstract selection for ISCOMS
Anke Berg, van den (Contributor)
15-Feb-2021
Activity: Organising and attending an event › Organising and contributing to an event › Academic

UMCG gaat zelf medicijn tegen lymfeklierkanker maken
Tom Meerten, van
26/09/2021
1 Media contribution
Press/Media: Other › Popular
€ 30 miljoen subsidie voor UMCG-onderzoek naar veelbelovende kankerbehandeling
Tom Meerten, van
24/09/2020
1 Media contribution
Press/Media: Other › Popular
Gronings ziekenhuis gaat prijzig kankermedicijn zelf maken met miljoenensubsidie
Tom Meerten, van
24/09/2020
1 Media contribution
Press/Media: Public Engagement Activities › Popular

Stem Cell Aging Leukemia and Lymphoma (SALL)

Network

Dive into details

Eugene Berezikov

Anke van den Berg

Edwin Bremer

Acute systemic loss of Mad2 leads to intestinal atrophy in adult mice

Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial

Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition

Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma [L1236]

Best paper of the year at annual Dutch Hematology Congress 2019

Differential drug sensitivity in pediatric brain cancer precursor cells: towards tailored treatments for infant and childhood medulloblastoma.

Dutch Cancer Society postdoctoral fellowship

PhD Mette Dahl

NextLevel Twinning project kickoff meeting

Abstract selection for ISCOMS

UMCG gaat zelf medicijn tegen lymfeklierkanker maken

€ 30 miljoen subsidie voor UMCG-onderzoek naar veelbelovende kankerbehandeling

Gronings ziekenhuis gaat prijzig kankermedicijn zelf maken met miljoenensubsidie